Consolidated Portfolio Review Corp’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-749
Closed -$279K 361
2025
Q3
$279K Buy
749
+101
+16% +$39K 0.04% 386
2025
Q2
$256K Buy
648
+26
+4% +$9.73K 0.04% 380
2025
Q1
$231K Buy
+622
New +$237K 0.04% 337
2024
Q1
Sell
-983
Closed -$294K 325
2023
Q4
$294K Buy
983
+34
+4% +$9.54K 0.07% 240
2023
Q3
$259K Buy
949
+4
+0.4% +$1.15K 0.06% 261
2023
Q2
$288K Buy
945
+50
+6% +$14.4K 0.07% 238
2023
Q1
$255K Buy
+895
New +$237K 0.07% 231

Other funds holding SYK

Consolidated Portfolio Review Corp's SYK Position: Q4 2025 in Review

Consolidated Portfolio Review Corp sold out of Stryker (SYK) in Q4 2025, closing a stake of 749 shares — an estimated $279K sold.

Consolidated Portfolio Review Corp first reported a position in SYK in Q1 2023 and held it in 7 quarters. The position peaked at $294K in Q4 2023. 2,325 funds tracked by Wall St. Rank hold SYK as of Q4 2025.

  • Consolidated Portfolio Review Corp reported no remaining Stryker position as of Q4 2025 after selling out during the quarter.
  • Consolidated Portfolio Review Corp sold 749 Stryker shares in Q4 2025, an estimated $279K.
  • Consolidated Portfolio Review Corp first reported a position in Stryker in Q1 2023 and held it in 7 quarters.
  • Consolidated Portfolio Review Corp's Stryker position peaked at $294K in Q4 2023.
  • 2,325 funds tracked by Wall St. Rank held Stryker as of Q4 2025.

Based on Consolidated Portfolio Review Corp's 13F filing for Q4 2025, filed 26 Jan 2026.